Total Hip Arthroplasty in Patients with Hemophilia: What Do We know?

Arch Bone Jt Surg. 2023;11(7):434-440. doi: 10.22038/ABJS.2023.58812.291.

Abstract

Total hip arthroplasty (THA) is the mainstay therapy for terminally hemophilic arthropathy patients. Hemophilic patients have distinguishing characteristics, including the increased likelihood of bleeding, younger age, restricted pre-operative joint motion, disrupted anatomy, and more post-operative side effects. The present study aimed to assess the THA sequels in hemophilic patients from various perspectives, including indications, challenges, factor replacement post-operative outcomes, and other complications.

Keywords: Hemophilia; Hemophilic arthropathy; Total hip arthroplasty.

Publication types

  • Review